New Developments in the Epidemiology of Cancer Prognosis: Traditional and Molecular Predictors of Treatment Response and Survival

There have been numerous epidemiologic investigations to determine factors that may affect cancer risk. There is also a rich tradition of evaluating potential somatic changes in the cancer itself to predict recurrence and/or mortality after diagnosis. However, there has been relatively little

[1]  J. Perlmutter From Cancer Patient to Cancer Survivor: Lost in Translation , 2006 .

[2]  K. Do,et al.  Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  C. Ulrich,et al.  Folate Supplementation: Too Much of a Good Thing? , 2006, Cancer Epidemiology Biomarkers & Prevention.

[4]  C. Ambrosone,et al.  Antioxidant Supplements, Genetics and Chemotherapy Outcomes , 2005 .

[5]  S. Freedland Obesity and Prostate Cancer: A Growing Problem , 2005, Clinical Cancer Research.

[6]  A. Neugut,et al.  Racial disparities in treatment and survival among women with early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  B. Pinto,et al.  Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Rui Mei,et al.  Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation , 2005, Human Genomics.

[9]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[11]  Young-In Kim Will mandatory folic acid fortification prevent or promote cancer? , 2004, The American journal of clinical nutrition.

[12]  C. Rock,et al.  Antioxidant supplement use in cancer survivors and the general population. , 2004, The Journal of nutrition.

[13]  R. Coates,et al.  Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma , 2004, Cancer.

[14]  Graham A Colditz,et al.  Physical activity and survival after breast cancer diagnosis. , 2004, JAMA.

[15]  M. Banerjee,et al.  The effect of race/ethnicity on prostate cancer treatment outcome is conditional: a review of Wayne State University data. , 2004, The Journal of urology.

[16]  M. Terris,et al.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Kelly,et al.  Antioxidants and cancer therapy: a systematic review. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Tim Byers,et al.  Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.

[19]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[20]  O. Brawley Disaggregating the effects of race and poverty on breast cancer outcomes. , 2002, Journal of the National Cancer Institute.

[21]  R. Bast,et al.  2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Patricia A. Ganz,et al.  From cancer patient to cancer survivor : lost in transition , 2006 .